Severe Immune Thrombocytopenia after COVID-19 Vaccination: Two Case Reports and a Literature Review
Takuto Shonai1,2, Fumihiko Kimura2, Junichi Watanabe1
1Department of Hematology, TMG Asaka Medical Center, Japan.
Abstract:
We herein report two cases of coronavirus disease 2019 (COVID-19) vaccine-induced immune thrombocytopenia (ITP). A 69-year-old Japanese man developed severe thrombocytopenia after COVID-19 vaccination. He had oral bleeding and hemoptysis but no thrombotic symptoms. He improved rapidly with oral prednisolone therapy. A 34-year-old Japanese woman had generalized purpura after COVID-19 vaccination. Her platelet count improved rapidly after treatment with prednisolone and eltrombopag. The occurrence of two cases of ITP after COVID-19 vaccination at a single institution suggests that there could be more such undiagnosed cases, especially cases of mild secondary ITP.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Myocarditis III: Medical Management
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Endocarditis II: Clinical Features of Infective Endocarditis
Venous Thrombosis I: Introduction
Vaccinations


